Unicorn AIM VCT Reports Challenging Half-Year with NAV Decline, Declares Dividend and Highlights Fundraising Success

Well, well, well. If there’s one thing we’ve learned from decades of market cycles, it’s that patience is the ultimate currency in small-cap investing. Unicorn AIM VCT’s latest half-year report reads like a masterclass in navigating choppy waters – complete with a few battle scars and some intriguing silver linings.

The Headline Numbers: NAV Dip and Dividend Grit

Let’s cut straight to the chase:

• NAV total return: -6.9% (vs FTSE AIM All-Share’s -7.1%)
• Interim dividend: 3.0p declared
• Special dividend: 6.0p already paid
• Fundraising: £24.1m net from oversubscribed offer

While the NAV decline stings, outperforming the benchmark by 20 basis points in this environment is like winning a limbo contest during an earthquake – not glamorous, but technically impressive.

Market Context: Groundhog Day for UK Small Caps

Chair Tim Woodcock doesn’t sugarcoat the “depressingly familiar” cocktail of challenges:

• UK core inflation sticking like chewing gum to a shoe
• Interest rates doing their best imitation of Mount Everest
• GDP growth moving at geological timescales

The result? A brutal -7.1% return for the FTSE AIM All-Share. Meanwhile, the FTSE 100’s +5.9% return highlights the growing chasm between large-cap havens and small-cap turbulence.

Silver Linings Playbook

• IPO thaw: 5 new AIM listings in Q1 2025
• M&A momentum: Hungry acquirers circling undervalued UK assets
• Special dividends: Liquidity events delivering shareholder payouts

Portfolio Spotlight: Heroes and Villains

Let’s dissect the star performers and cautionary tales:

Top 3 Contributors

• SulNOx Group (+£4.22m): This greentech play saw sales rocket 173% as shipping giants scramble for emission solutions. Proof that ESG investing can be both virtuous and lucrative.
• Cohort (+£2.96m): Defence stocks aren’t just for war documentaries. With a £291.5m order book and strategic acquisitions, this one’s firing on all cylinders.
• Hasgrove (+£2.64m): The unquoted SaaS dark horse delivering 23.5% portfolio weighting. When private markets outperform public, it’s a telling market signal.

Bottom 3 Draggers

• Tracsis (-£2.97m): Transport tech hit by political paralysis and delayed disposals. A case study in how infrastructure indecision ripples through markets.
• Aurrigo (-£2.32m): Autonomous baggage handlers sound futuristic, but burning £1.9m EBITDA shows the cost of being first to market.
• Futura Medical (-£1.40m): Eroxon’s sluggish US uptake proves that disrupting… ahem… male performance markets requires more than good science.

Strategic Moves: Cash Cannons and Shareholder Chess

• £17.3m new investments: Mixing fresh bets (£4.3m) with follow-ons (£5.5m) shows disciplined doubling down
• 3.1m shares bought back: Opportunistic repurchases at 84.49p average – a nod to the persistent share price discount
• DRIS uptake: 2.96m shares issued through dividend reinvestment – smart retention of patient capital

The Elephant in the Room: US Policy Wildcard

Woodcock’s warning about “growing unpredictability of U.S. economic policy” deserves a highlight. With 23.5% portfolio exposure to Hasgrove’s global SaaS play and Cohort’s Australian acquisition, geopolitical risk isn’t just theoretical here.

VCT Compliance: Safety First

93% qualifying holdings (excl. new raises) keeps the taxman happy. But that sanctions checking note? A bureaucratic landmine for dividend recipients. Pro tip: If you haven’t sent your DOB to the registrar, do it before 11 July – nobody likes missing a payout.

Looking Ahead: Light at the Tunnel’s End?

The Board’s mantra – “patience, discipline, and long-term perspective” – feels appropriate. With:

• £6.7m cash war chest
• £17.5m in liquid listed stocks
• M&A tailwinds strengthening

This VCT’s positioned to play both defence and offence. The real question? Whether 2025’s second half brings the long-awaited mean reversion in small-cap valuations.

Final thought: In a market where 3p dividends feel like manna from heaven, Unicorn’s ability to maintain payouts while navigating portfolio headwinds speaks volumes about its balance sheet discipline. Not a smooth ride, but the wheels remain firmly attached.